AnaptysBio, Inc.ANABNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 75 | 63↓15.8% | 10↓83.7% | 17↑66.8% | 91↑432.0% |
| Gross Profit | -5 | -35↓602.9% | -79↓122.3% | -115↓46.6% | -73↑37.0% |
| Operating Income | -24 | -57↓137.9% | -115↓102.7% | -164↓42.8% | -115↑30.1% |
| Net Income | -20 | -58↓190.0% | -129↓122.7% | -164↓27.1% | -145↑11.2% |
| EBITDA | -19 | -56↓187.6% | -105↓89.0% | -156↓48.6% | -93↑40.7% |
| EPS Diluted | -0.73 | -2.11↓189.0% | -4.57↓116.6% | -6.08↓33.0% | -5.12↑15.8% |